Distillation technology and research and development for new chemical substances
First written in FY2017. 14 of 15 entries say "Restated". Latest entry: FY2024-Q2.
No other company in this theme has enough history to compare yet.
- FY2024-Q2RestatedAnnual report
「Total research and development expenses for the cumulative second quarter of the current consolidated fiscal year were ¥1.042 million, attributable to the Contract Distillation Business segment.」
The company continues research and development activities in the Contract Distillation Business and disclosed research and development expenses of ¥1.042 million for the cumulative quarter. - FY2023-Q3RestatedAnnual report
「Total research and development expenses for the cumulative third quarter of the current consolidated fiscal year were ¥9.179 million, attributable to the Contract Distillation Business segment.」
The company continues research and development activities in the Contract Distillation Business and recorded ¥9.179 million in research and development expenses. - FY2023-Q2RestatedAnnual report
「Total research and development expenses for the cumulative second quarter of the current consolidated fiscal year were ¥8.029 million, attributable to the Contract Distillation Business segment.」
The company continues research and development activities in the Contract Distillation Business and recorded ¥8.029 million in research and development expenses. - FY2023-Q1RestatedAnnual report
「Total research and development expenses for the cumulative first quarter of the current consolidated fiscal year were ¥3.854 million, attributable to the Contract Distillation Business segment.」
The company continues research and development activities in the Contract Distillation Business and recorded ¥3.854 million in research and development expenses. - FY2022-Q3RestatedAnnual report
「Total research and development expenses for the cumulative third quarter of the current consolidated fiscal year were ¥12.896 million, attributable to the Contract Distillation Business segment.」
The company continues research and development activities in the Contract Distillation Business and recorded ¥12.896 million in research and development expenses. - FY2022-Q2RestatedAnnual report
「Total research and development expenses for the cumulative second quarter of the current consolidated fiscal year were ¥7.391 million, attributable to the Contract Distillation Business segment.」
The company continues research and development activities in the Contract Distillation Business and recorded ¥7.391 million in research and development expenses. - FY2022-Q1RestatedAnnual report
「Total research and development expenses for the cumulative first quarter of the current consolidated fiscal year were ¥6.213 million, attributable to the Contract Distillation Business segment.」
The company continues research and development activities in the Contract Distillation Business and recorded ¥6.213 million in research and development expenses. - FY2021RestatedAnnual report
「To strengthen and expand its core business and meet customer requirements, the Group conducts research and development into distillation technology in collaboration with corporate research and development departments, universities and other research institutions. It is conducting research and development aimed at designing and establishing efficient and optimal purification methods for new chemical substances. Total research and development expenses for the consolidated fiscal year were ¥15.573 million, incurred in the Contract Distillation Business.」
The company continues research into distillation technology in collaboration with companies, universities and other institutions, as well as the design and establishment of purification methods for new chemical substances. Research and development expenses were ¥15.573 million. - FY2021-Q3RestatedAnnual report
「Total research and development expenses for the cumulative third quarter of the current consolidated fiscal year were ¥14.365 million, attributable to the Contract Distillation Business segment.」
The company continues research and development activities in the Contract Distillation Business and recorded ¥14.365 million in research and development expenses. - FY2021-Q2RestatedAnnual report
「Total research and development expenses for the cumulative second quarter of the current consolidated fiscal year were ¥10.450 million, attributable to the Contract Distillation Business segment.」
The company continues research and development activities in the Contract Distillation Business and recorded ¥10.450 million in research and development expenses. - FY2020-Q3RestatedAnnual report
「Total research and development expenses for the cumulative third quarter of the current consolidated fiscal year were ¥15.636 million, attributable to the Contract Distillation Business segment.」
The company continues research and development activities in the Contract Distillation Business and recorded ¥15.636 million in research and development expenses. - FY2020-Q2RestatedAnnual report
「Total research and development expenses for the cumulative second quarter of the current consolidated fiscal year were ¥13.210 million, attributable to the Contract Distillation Business segment.」
The company continues research and development activities in the Contract Distillation Business and recorded ¥13.210 million in research and development expenses. - FY2019RestatedAnnual report
「The company conducts research and development into distillation technology in collaboration with corporate research and development departments, universities and other research institutions. It is also conducting research and development aimed at designing and establishing efficient and optimal purification methods for new chemical substances.」
The company continues research into distillation technology in collaboration with companies, universities and other institutions, as well as its research and development objective of designing and establishing purification methods for new chemical substances. Research and development expenses are reported at ¥25.873 million. - FY2018RestatedAnnual report
「The company is conducting research and development aimed at designing and establishing efficient and optimal purification methods for new chemical substances.」
The company continues to pursue its research and development objective of designing and establishing purification methods for new chemical substances. - FY2017First statedAnnual report
「The company is conducting research and development aimed at designing and establishing efficient and optimal purification methods for new chemical substances.」
The company’s research and development objective is to design and establish purification methods for new chemical substances in collaboration with companies, universities and other institutions.